2022
Suh M , Movva N , Jiang X , Bylsma LC , Reichert H , Fryzek JP, Nelson CB. 2022. Respiratory syncytial virus (RSV) is the leading cause of United States infant hospitalizations 2009–2019: A study of the National (Nationwide) Inpatient Sample. J Infect Dis 226(Suppl 2):S154–S163; doi: 10.1093/infdis/jiac120 . PMID: 35968878.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology
Bylsma L , Fryzek J, Movva N , Frankenfeld C , Hooda N , Pundole X, et al. 2022. Systematic literature review of the prevalence and prognostic value of delta-like ligand 3 protein expression in small cell lung cancer. PROSPERO 2022 CRD42022351119
View Abstract
Publication: Protocol Registrations
/ Topics: Cancer , Epidemiology , Systematic Review
Rankin DA, Haddadin Z, Lipworth L, Stahl AL, Fryzek J, Suh M , et al. 2022. Comparison of clinical presentations and burden of respiratory syncytial virus in infants across three distinct healthcare settings in Davidson County, Tennessee. Therapeut Adv Infect Dis 9(July 18):20499361221112171; doi: 10.1177/20499361221112171 . PMID: 35875809.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Pang F, Dean R, Jensen I , Tehard B, Roze S, Olaye A, et al. The cost-effectiveness of atidarsagene autotemcel for the treatment of metachromatic leukodystrophy (MLD) in France. Abstract EE24 , ISPOR 2022.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Bonkowsky J, Healey B, Sacks NC, Mclin R, Cyr PL , Sawyer E, Stephen CB, et al. Burden of illness and mortality in adult men with adrenomyeloneuropathy: A retrospective study of real-world data. American Academy of Neurology, Seattle, WA, 2022
Publication: Abstracts and Presentations
/ Topics: Epidemiology
Jensen IS , Wu E, Cyr PL , Claussen M, Winkler T, Salahuddin K, Prats J, et al. 2022. Cost-consequence analysis of using cangrelor in high angiographic risk percutaneous coronary intervention patients: A US hospital perspective. Am J Cardiovasc Drugs 22(1):93-104; doi: 10.1007/s40256-021-00491-9 . PMID: 34331235.
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Alexander AW, Jensen IJ , Hathaway J, Srivastava K, Cyr PL , Sidonio RF, Batt K. 2022. Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements. J Manag Care Spec Pharm 28(5):518-527; doi: 10.18553/jmcp.2022.21197 . PMID: 35343812.
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Fryzek J, Frankenfeld C , Movva N , Bylsma L , Aquavella J. 2022. Insights into epidemiology. Chapter 21 in: Roberts SM, James RC, Williams PL (Eds), Principles of Toxicology: Environmental and Industrial Applications, Fourth edition. John Wiley & Sons, Inc., Hoboken, NJ, EISBN 1119635195.
View Abstract